- Report
- November 2020
- 162 Pages
North America
From €3031EUR$3,450USD£2,615GBP
- Report
- February 2024
- 120 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- February 2024
- 120 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- February 2024
- 111 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- February 2024
- 140 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 106 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 71 Pages
Italy
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 85 Pages
Australia
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 110 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 117 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 130 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 61 Pages
Mexico
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 75 Pages
South Korea
From €4174EUR$4,750USD£3,600GBP
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 90 Pages
China
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 69 Pages
United Kingdom
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 111 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 120 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- August 2022
- 134 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- January 2022
- 117 Pages
Global
From €4174EUR$4,750USD£3,600GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more